Literature DB >> 32715008

No needle to fear: An approach to needle phobic patients.

Lauren Hudswell1, Joanne Pinson1, Shakher Ramdave1, Jason Bradley1.   

Abstract

18F-FDG is the most commonly used radioisotope in PET scanning and is administered intravenously. When patients cannot cannulated, there are limited options available for functional tumour assessment. A fifty year old male presented for investigation of a suspected lung carcinoma identified during investigation of pneumonia. The patient had a severe needle phobia, intellectual disabilities and multiple co-morbidities which made cannulation impossible. An alternative administration method was sought, with successful oral administration occurring in both staging and restaging scans. The scans demonstrated resolution of a suspected lung cancer indicating it was an inflammatory/infective process, preventing the need for more invasive investigative approaches. A non-invasive and positive experience allowed for accurate diagnosis and repeat imaging for this patient, enabling follow up imaging to occur. It is reported that oral administration of 18F-FDG may be useful for assessment of suspected cancers for patients where cannulation isn't possible, when limitations are taken into consideration.
© 2020 mums.ac.ir All rights reserved.

Entities:  

Keywords:  18F-FDG; Non-invasive; Oral administration

Year:  2020        PMID: 32715008      PMCID: PMC7354238          DOI: 10.22038/AOJNMB.2020.45184.1304

Source DB:  PubMed          Journal:  Asia Ocean J Nucl Med Biol        ISSN: 2322-5718


  7 in total

1.  Substitution of oral (18)F-FDG for intravenous (18)F-FDG in PET scanning.

Authors:  Narendra Nair; Archi Agrawal; Rajnath Jaiswar
Journal:  J Nucl Med Technol       Date:  2007-05-11

Review 2.  Glucose absorption in small intestinal diseases.

Authors:  Sony S Thazhath; Tongzhi Wu; Richard L Young; Michael Horowitz; Christopher K Rayner
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-02-06       Impact factor: 3.869

Review 3.  Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders.

Authors:  Andrew Newberg; Abass Alavi; Martin Reivich
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

4.  Dynamic observation of 18F-FDG uptake after oral administration in a healthy subject.

Authors:  Kaixiu Zhang; Xuemei Wang; Linjun Hao; Zhenfeng Zhao; Chunlei Han
Journal:  J Nucl Med Technol       Date:  2013-04-22

5.  Oral administration of F-18 FDG to evaluate a single pulmonary nodule by positron emission tomography in a patient with poor intravenous access.

Authors:  Benjamin Franc; Marie R Carlisle; George Segall
Journal:  Clin Nucl Med       Date:  2003-07       Impact factor: 7.794

6.  Comparison of the Intraperitoneal, Retroorbital and per Oral Routes for F-18 FDG Administration as Effective Alternatives to Intravenous Administration in Mouse Tumor Models Using Small Animal PET/CT Studies.

Authors:  Chulhan Kim; In Hye Kim; Seo-Il Kim; Young Sang Kim; Se Hun Kang; Seung Hwan Moon; Tae-Sung Kim; Seok-Ki Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-05-27

7.  Human Radiation Dosimetry for Orally and Intravenously Administered 18F-FDG.

Authors:  Senthamizhchelvan Srinivasan; John P Crandall; Prateek Gajwani; George Sgouros; Esther Mena; Martin A Lodge; Richard L Wahl
Journal:  J Nucl Med       Date:  2019-10-18       Impact factor: 11.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.